BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18596414)

  • 1. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
    Han YH; Kim SZ; Kim SH; Park WH
    Mol Cells; 2008 Aug; 26(2):158-64. PubMed ID: 18596414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine.
    Han YH; Kim SZ; Kim SH; Park WH
    Int J Oncol; 2008 Jul; 33(1):205-13. PubMed ID: 18575767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
    Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
    You BR; Park WH
    Oncol Rep; 2012 Aug; 28(2):749-57. PubMed ID: 22684917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
    Han YH; Kim SZ; Kim SH; Park WH
    Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
    Gu S; Chen C; Jiang X; Zhang Z
    Wei Sheng Yan Jiu; 2016 Jan; 45(1):87-92. PubMed ID: 26987203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H; Hori S; Ohizumi H; Segawa T; Kakehi Y; Ogawa O; Kakizuka A
    Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine.
    Tanaka Y; Komatsu T; Shigemi H; Yamauchi T; Fujii Y
    BMC Cancer; 2014 Jan; 14():27. PubMed ID: 24428916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
    Duechler M; Stańczyk M; Czyz M; Stepnik M
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):727-37. PubMed ID: 17594095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of arsenic trioxide on cell death, reactive oxygen species and glutathione levels in different cell types.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2010 Jan; 25(1):121-8. PubMed ID: 19956910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
    Ramos AM; Aller P
    Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis.
    Chen H; Gu S; Dai H; Li X; Zhang Z
    Biol Trace Elem Res; 2017 Oct; 179(2):203-212. PubMed ID: 28261759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in arsenic trioxide-treated Calu-6 lung cells is correlated with the depletion of GSH levels rather than the changes of ROS levels.
    Han YH; Kim SH; Kim SZ; Park WH
    J Cell Biochem; 2008 Jun; 104(3):862-78. PubMed ID: 18393359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
    Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
    Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.